Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Sofinnova Management VIII, L.L.C. — ALIMERA SCIENCES INC insider · InsiderLens

Home / Insiders / Sofinnova Management VIII, L.L.C.

Sofinnova Management VIII, L.L.C.

10% owner at ALIMERA SCIENCES INC · on record since Oct 4, 2012
10% owner at Versartis, Inc. · on record since Mar 28, 2014
10% owner at Ocugen, Inc. · on record since Dec 10, 2014
10% owner at One e Commerce CORP · on record since Jan 29, 2015
10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
10% owner at Aclaris Therapeutics, Inc. · on record since Oct 13, 2015
10% owner at Principia Biopharma Inc. · on record since Sep 20, 2018

Insider trading activity of Sofinnova Management VIII, L.L.C.

No transactions on record for Sofinnova Management VIII, L.L.C..

Track record of Sofinnova Management VIII, L.L.C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Sofinnova Management VIII, L.L.C.

Co-insiders of Sofinnova Management VIII, L.L.C.

AKKARAJU SRINIVASAclaris Therapeutics, Inc. +6
HEALY JAMESAclaris Therapeutics, Inc. +6
Mehra AnandAclaris Therapeutics, Inc. +6
POWELL MICHAELAclaris Therapeutics, Inc. +6
Sofinnova Venture Partners VIII, L.P.Aclaris Therapeutics, Inc. +6
Kong GarhengALIMERA SCIENCES INC +1
MILANO VINCENTAclaris Therapeutics, Inc. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

New Leaf Venture Associates II, L.P.Principia Biopharma Inc. +1

New Leaf Venture Management II, L.L.C.Principia Biopharma Inc. +1

New Leaf Ventures II, L.P.Principia Biopharma Inc. +1

ORBIMED ADVISORS LLCMirna Therapeutics, Inc. +1

SCHIFF ANDREW NAclaris Therapeutics, Inc. +1

Advent Life Sciences Fund I LPVersartis, Inc.

Advent Life Sciences LLPVersartis, Inc.

AISLING CAPITAL III LPVersartis, Inc.

Aisling Capital Partners III LLCVersartis, Inc.

Aisling Capital Partners III LPVersartis, Inc.

Ali-Jackson KamilAclaris Therapeutics, Inc.

Alleva Lawrence MMirna Therapeutics, Inc.

Altschuler StevenOne e Commerce CORP

ARMISTICE CAPITAL, LLCALIMERA SCIENCES INC

Armistice Capital Master Fund Ltd.ALIMERA SCIENCES INC

Arumugham RasappaOcugen, Inc.

Ashman PhilipALIMERA SCIENCES INC

Atlas Venture Fund IX, L.P.Mirna Therapeutics, Inc.

Awad AntoineMirna Therapeutics, Inc.

Babler MartinPrincipia Biopharma Inc.

Baker Bros. Advisors (GP) LLCPrincipia Biopharma Inc.

BAKER BROS. ADVISORS LPPrincipia Biopharma Inc.

BAKER FELIXPrincipia Biopharma Inc.

BAKER JULIANPrincipia Biopharma Inc.

Balthaser KevinAclaris Therapeutics, Inc.

Baltzell Joshua JOcugen, Inc.

Barbosa MiguelMirna Therapeutics, Inc.

BARRETT M JAMESMirna Therapeutics, Inc.

Barrett PeterMirna Therapeutics, Inc.

BARRIS PETER JMirna Therapeutics, Inc.

BASKETT FORESTMirna Therapeutics, Inc.

BA Venture Partners VI, LLCALIMERA SCIENCES INC

BAVP, L.P.ALIMERA SCIENCES INC

Becker Daniel J.Principia Biopharma Inc.

Beck KellyOcugen, Inc.

BELOFF GREGGMirna Therapeutics, Inc.

Betz Alert LorrisOne e Commerce CORP

Bierly RickAclaris Therapeutics, Inc.

Biosion, Inc.Aclaris Therapeutics, Inc.

BIOTECHNOLOGY VALUE FUND II LPPrincipia Biopharma Inc.

BIOTECHNOLOGY VALUE FUND L PPrincipia Biopharma Inc.

Biotechnology Value Trading Fund OS LPPrincipia Biopharma Inc.

BLAIR JAMES CALIMERA SCIENCES INC

No transactions on record. Reset filters